{"id":"placebo-for-ipilimumab","brandName":"Placebo for Ipilimumab","genericName":"Placebo for Ipilimumab","companyId":"bristol-myers-squibb","companyName":"Bristol-Myers Squibb","phase":"phase_3","status":"active","modality":"Biologic","aliases":[],"developmentCodes":[],"firstApprovalDate":null,"firstApprovalCountry":null,"aiSummary":"The placebo for Ipilimumab is used in clinical trials to assess the efficacy and safety of Ipilimumab and other immunotherapies. It has no active pharmacological properties but serves as a control in randomized studies.","enrichmentLevel":3,"visitCount":0,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"As a placebo, it does not interact with any biological pathways or receptors, and its purpose is to serve as a control in clinical trials.","oneSentence":"This is a placebo for Ipilimumab, meaning it has no active therapeutic effect.","_ai_confidence":"high"},"administration":{},"safety":{"commonSideEffects":[]},"trials":[],"indications":{"approved":[{"name":"Metastatic melanoma"}]},"commercial":null,"patents":[],"timeline":[],"rwe":[],"competitors":[],"ownershipHistory":[],"trialDetails":[],"genericFilers":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"labelChanges":[],"nice":null,"revenue":null,"trialStats":{"total":1,"withResults":1},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":false,"score":2}}